Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase II results presented for TB vaccine in HIV-infected adults

July 28, 2014

Gilead Sciences designs new anti-HIV agents

July 28, 2014

Results presented on MVTT-based HIV vaccine development

July 28, 2014

Novel agents for HIV infection patented by Gilead Sciences

July 28, 2014

HIV latency reversal achieved in patients with romidepsin

July 25, 2014

Bispecific, chimeric antibody-like immunoadhesin neutralizes HIV in vitro

July 24, 2014

MODERN study of maraviroc regimen in HIV-1 infection does not meet primary endpoint

July 24, 2014

Development of a live-attenuated HIV-1 virus incapable of reactivation

July 23, 2014

MARCH8 protein blocks HIV-1 infection

July 22, 2014

Japan Tobacco describes new HIV integrase inhibitors

July 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...